Anupam Rama - JPMorgan Chase & Co. Analyst Performance This page shows the methodology used to calculate Anupam Rama's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily. MarketBeat Analyst Ranking: Subscribe to MarketBeat All Access for the recommendation accuracy ratingAverage 12-Month ROI of Buy and Strong Buy Recommendations: ???% Export to Excel CompanyReport DateReport Date Price12-MonthPrice TargetRating12-MonthActual Price12-MonthROIDetailsREPLReplimune Group7/16/2025$12.40$19.00Overweight???%???%COGTCogent Biosciences7/10/2025$11.02$29.00Overweight???%???%SRPTSarepta Therapeutics7/10/2025$19.01$28.00Overweight???%???%COGTCogent Biosciences5/29/2025$5.22$25.00Overweight???%???%IDYAIDEAYA Biosciences5/22/2025$19.04$66.00Overweight???%???%SRPTSarepta Therapeutics5/20/2025$37.68$84.00Overweight???%???%OLMAOlema Pharmaceuticals3/28/2025$4.20$28.00Overweight???%???%RAREUltragenyx Pharmaceutical3/27/2025$38.88$117.00Overweight???%???%NBIXNeurocrine Biosciences3/26/2025$116.18$184.00Overweight???%???%BBIOBridgeBio Pharma3/24/2025$34.77$50.00Overweight???%???%SNDXSyndax Pharmaceuticals3/20/2025$13.84$41.00Overweight???%???%ZLABZai Lab3/13/2025$36.14$51.00Overweight???%???%SLDBSolid Biosciences3/13/2025$5.15$11.00Overweight???%???%ANABAnaptysBio3/5/2025$15.19$42.00Overweight???%???%DAWNDay One Biopharmaceuticals3/5/2025$9.32$34.00Overweight???%???%SNDXSyndax Pharmaceuticals3/4/2025$14.46$39.00Overweight???%???%APLSApellis Pharmaceuticals3/4/2025$24.65$54.00Overweight???%???%VERAVera Therapeutics3/4/2025$28.66$71.00Overweight???%???%TVTXTravere Therapeutics2/26/2025$21.45$44.00Overweight???%???%REPLReplimune Group2/26/2025$13.60$18.00Overweight???%???%ORICOric Pharmaceuticals2/26/2025$8.69$22.00Overweight???%???%MAZEMaze Therapeutics2/25/2025$10.82$30.00Overweight???%???%ORICOric Pharmaceuticals2/6/2025$12.72$21.00Overweight???%???%SNDXSyndax Pharmaceuticals3/7/2023$24.23$36.00Overweight???%???%NBIXNeurocrine Biosciences4/4/2022$97.48$126.00Overweight???%???%SRPTSarepta Therapeutics11/5/2021$86.97$130.00Overweight???%???%GTHXG1 Therapeutics11/4/2021$16.16$19.00Underweight???%???%PTGXProtagonist Therapeutics10/12/2021$35.36$55.00Overweight???%???%GTHXG1 Therapeutics10/6/2021$12.66$20.00Hold???%???%SWTXSpringWorks Therapeutics9/8/2021$69.38$105.00Overweight???%???%INFIInfinity Pharmaceuticals8/2/2021$2.12$6.00Overweight???%???%APLSApellis Pharmaceuticals7/2/2021$67.80$101.00Overweight???%???%VIRVir Biotechnology9/11/2020$28.28$29.00Neutral???%???%PASGPassage Bio8/14/2020$295.40$500.00Neutral???%???%SRPTSarepta Therapeutics6/22/2020$170.62$190.00Overweight???%???%FOLDAmicus Therapeutics6/8/2020$11.73Buy???%???%SRPTSarepta Therapeutics5/15/2020$141.25Buy???%???%AGIOAgios Pharmaceuticals5/4/2020$37.01$82.00Overweight???%???%VIRVir Biotechnology3/19/2020$49.00$26.00Underweight???%???%CCXIChemoCentryx3/11/2020$43.52$61.00Overweight???%???%OYSTOyster Point Pharma3/6/2020$31.51$50.00???%???%CCXIChemoCentryx2/18/2020$48.00$60.00Positive???%???%MYOKMyoKardia2/7/2020$70.37Buy???%???%AGIOAgios Pharmaceuticals1/31/2020$48.73Buy???%???%CCXIChemoCentryx11/26/2019$8.06$28.00Positive???%???%CCXIChemoCentryx10/15/2019$7.94Buy???%???%ALNYAlnylam Pharmaceuticals11/9/2017$132.33Overweight???%???%FOLDAmicus Therapeutics10/4/2017$16.24Overweight???%???%ARRYArray Technologies9/11/2017$10.98$14.00Buy???%???%ALXNAlexion Pharmaceuticals9/5/2017$144.08$175.00Overweight???%???%FOLDAmicus Therapeutics8/9/2017$12.58$15.00Overweight???%???%IRWDIronwood Pharmaceuticals7/21/2017$17.00$19.00Neutral???%???%ALNYAlnylam Pharmaceuticals6/26/2017$82.92Hold???%???%ALXNAlexion Pharmaceuticals6/14/2017$118.00Hold???%???%FOLDAmicus Therapeutics6/5/2017$8.52$13.00Buy???%???%NBIXNeurocrine Biosciences5/24/2017$48.89$57.00Buy???%???%ALXNAlexion Pharmaceuticals5/23/2017$115.42Neutral???%???%ARRYArray Technologies5/3/2017$7.38$10.00Overweight???%???%NBIXNeurocrine Biosciences4/12/2017$51.80$60.00Buy???%???%ARRYArray Technologies3/20/2017$10.07$9.00Hold???%???%SRPTSarepta Therapeutics3/11/2017$32.63$42.00Buy???%???%ALXNAlexion Pharmaceuticals2/7/2017$128.19$170.00Buy???%???%IRWDIronwood Pharmaceuticals2/2/2017$15.46$21.00Buy???%???%OPHTIVERIC bio12/12/2016$38.77$11.00Neutral???%???%ALXNAlexion Pharmaceuticals12/12/2016$115.08Buy???%???%OPHTIVERIC bio9/8/2016$54.19$95.00Overweight???%???%ALNYAlnylam Pharmaceuticals8/5/2016$71.03$83.00Overweight???%???%PTCTPTC Therapeutics8/5/2016$7.77$17.00Neutral???%???%RIGLRigel Pharmaceuticals8/3/2016$28.70$50.00Buy???%???%INFIInfinity Pharmaceuticals6/14/2016$4.41Neutral???%???%AGIOAgios Pharmaceuticals6/13/2016$50.35$62.00Overweight???%???%AGIOAgios Pharmaceuticals6/10/2016$50.35$62.00Overweight???%???%NBIXNeurocrine Biosciences5/4/2016$42.91Buy???%???%NBIXNeurocrine Biosciences4/12/2016$44.72Buy???%???%AGIOAgios Pharmaceuticals3/31/2016$40.60Hold???%???%MESOMesoblast3/7/2016$18.36$20.00Neutral???%???%PTCTPTC Therapeutics2/23/2016$28.26$22.00Neutral???%???%FOLDAmicus Therapeutics2/23/2016$7.16$15.00Buy???%???%NBIXNeurocrine Biosciences2/9/2016$32.51$63.00Buy???%???%PTCTPTC Therapeutics10/16/2015$31.74$84.00Overweight???%???%NBIXNeurocrine Biosciences10/8/2015$43.60Buy???%???%CCXIChemoCentryx9/24/2015$6.35Buy???%???%NBIXNeurocrine Biosciences9/10/2015$50.50Buy???%???% Return to Analyst Rankings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
